<DOC>
	<DOCNO>NCT02445534</DOCNO>
	<brief_summary>Although several study demonstrate beneficial effect stem cell therapy patient non-ischemic dilated cardiomyopathy , long term benefit predictor response therapy remain undefined . The aim registry pool long-term clinical data patient non-ischemic dilated cardiomyopathy undergo autologous cell therapy attempt well define predictor response treatment .</brief_summary>
	<brief_title>Registry Cell Therapy Non-Ischemic Dilated Cardiomyopathy</brief_title>
	<detailed_description>Registry include patient underwent intracoronary intramyocardial cell therapy part clinical trial perform UMC Ljubljana January 2005 January 2018 . Patients follow regular basis dedicate heart failure outpatient clinic , clinical data collect stored secure central database . Data analyze periodic interval independent Data monitoring board attempt well define predictor clinical response cell therapy patient population .</detailed_description>
	<mesh_term>Cardiomyopathies</mesh_term>
	<mesh_term>Cardiomyopathy , Dilated</mesh_term>
	<criteria>Patient inclusion criterion consist follow : age 1865 year old , diagnosis DCM accord European Society Cardiology position statement ( 9 ) , optimal medical management least 6 month , leave ventricular ejection fraction ( LVEF ) &lt; 40 % , New York Heart Association functional Class III stable medical therapy least 3 month referral . Patients acute multiorgan failure history hematologic neoplasm include .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>Cell Therapy</keyword>
</DOC>